translational genomics research institute Archives

Destroy Pancreatic Cancer will fund Phoenix clinical trial

Destroy Pancreatic Cancer, a nonprofit organization with the goal of funding clinical trials and advancing research that leads to earlier detection and improved treatment options for pancreatic cancer, the third leading cause of cancer deaths in the U.S., today announced its official launch. Howard Young, a 15-year pancreatic cancer survivor, will lead the foundation. Clinical trials will be… Read More →

Arizona’s MedTech sector makes big impact on Bioscience Roadmap

Arizona’s technology community and the Bioscience Roadmap have become driving forces behind the economic success of our state. The industry plays a significant role in almost every sector of the business landscape and the work of its leaders is putting our state on the map as a nationwide contender. Two industries in which technology and… Read More →

TGen ties global fungus to continental drift

Healthcare

Cryptococcus, a type of fungi found worldwide that is responsible annually for upwards of 625,000 deaths, was likely originally spread across the globe in conjunction with continental drift, according to a report by Tgen (the Translational Genomics Research Institute). Cryptococcus — Greek for “hidden sphere” — is a fungus usually found in decaying trees and… Read More →

15 healthcare innovations that are impacting Arizona

The health of Arizona remains a concern. Arizona residents’ health is below average. The state ranks as the 29th healthiest in the nation, according to United Health Foundation’s 2016 America’s Health Rankings Annual Report. The good news is that the No. 29 ranking was an improvement over the previous year, when Arizona ranked 30th. But… Read More →

Top deal: GlobalTranz purchase of Global Freight Source

The purchase of Milwaukee-based Global Freight Source by Valley-based GlobalTranz has been selected as the 2016 Deal of the Year Award by the Association for Corporate Growth-Arizona Chapter. The “Deal of the Year” is an award given by the Arizona Chapter of the Association for Corporate Growth (ACG) to recognize a company or private equity… Read More →

TGen and UNC Lineberger shed light on aggressive brain cancer

Two studies by researchers at the Translational Genomics Research Institute (TGen) and the University of North Carolina Lineberger Comprehensive Cancer Center (UNC Lineberger) provide insight on the evolution of glioblastoma and how to potentially combat this most aggressive brain tumor. Both studies were published recently in the scientific journal Neuro-Oncology, and both were funded, in… Read More →

ACG names finalists for Arizona Deal of the Year

Three finalists have been announced for the award recognizing the most significant mergers and acquisitions transactions that took place in Arizona in calendar year 2016. The “Deal of the Year” is an award given by the Arizona Chapter of the Association for Corporate Growth (ACG) to recognize a company or private equity firm for their accomplishments regarding a merger, acquisition or capital… Read More →

TGen concussion study may lead to better diagnosis, treatment

TGen concussion study of ASU football players
by in Bioscience | Healthcare

A three-year study of the Arizona State University football team will help researchers develop tools to better diagnose and prevent sports-related concussions and other injuries or diseases. The study, conducted by the Translational Genomics Research Institute, drew data from sensors placed inside players’ helmets during practices and games from 2013 to 2016. It combined the… Read More →

BestCompaniesAZ names 100 Best Companies in Arizona

It is the purpose of BestCompaniesAZ and our calling – and has been for 15 years. We knew that better workplaces would create better lives, better communities, and more profitable businesses. Although it wasn’t about the money, the financial success was proven to be a benefit for best companies. Ten years ago, we were excited… Read More →

TGen finds mutation linked to child’s development

Researchers at TGen (Translational Genomics Research Institute) have identified a genomic mutation that causes physical abnormalities and developmental delays in children. Upon analyzing the genome of a six-year-old boy, the scientists identified a novel mutation that affects a protein known as CASK, which is key to brain development and the signals transmitted by brain cells,… Read More →

20 influential Millennials working in Arizona

Influential millennials
by in AZ Business Magazine

Can you guess the average tenure of Millennial employees? Two years. That doesn’t instill much confidence for human resources executives who are trying to create a stable workforce, especially when you take this into account: More than one-in-three American workers today are Millennials (adults ages 18 to 36). And in 2015, Millennials surpassed Generation X… Read More →

NCI funds TGen-led cancer study training

brain cancer

The National Cancer Institute (NCI) awarded a 5-year, $1.125 million grant to continue an innovative and unique oncology training program for newly minted physicians developed and overseen by Dr. Daniel Von Hoff, distinguished professor and physician-in-chief at the Translational Genomics Research Institute (TGen). Convened by the American Association for Cancer Research (AACR) and the American Society… Read More →

TGen forges alliance with City of Hope

Cancer research

City of Hope, an independent research and cancer and diabetes treatment center, and Translational Genomics Research Institute (TGen), a biomedical research institute, have formed an alliance to make precision medicine a reality for patients, according to a Wednesday announcement. TGen remains an Arizona-based nonprofit with headquarters in Phoenix. As part of the agreement, TGen will join… Read More →

Dr. Daniel Von Hoff named a ‘Giant of Cancer Care’

Dr. Daniel Von Hoff, Physician-In-Chief and Distinguished Professor at the Translational Genomics Research Institute (TGen), has been selected as a 2016 Giant of Cancer Care. The award was announced today during the 34th annual Chemotherapy Foundation Symposium in New York. Dr. Von Hoff, a world-renowned expert in pancreatic cancer, was honored for his work in… Read More →